Jürgen Fortin is the founder and CEO of CNSystems. He is also a university lecturer and responsible for the company’s intellectual property being the author of 80 patents and several publications on current and future noninvasive technologies.
CEO CNSystems, Austria
| ******@***cnsystems.com |
2021 20 Oct
Initial Orthostatic Hypotension (OH) is described as a rapid and transient drop in blood pressure associated with the increased risk of falls, fractures and syncope, especially in the ageing population (Tran et al. 2021). As prevalence is high, the...
2021 01 Jun
Long COVID patients suffer from autonomic dysfunction with persistent long-term symptoms. CNSystems’ non-invasive technology significantly contributes to a well-founded cardiovascular diagnosis of COVID-19 survivors and enables a quick check of treatment...
2021 19 Apr
P atients and their families often fear surgical interventions due to possible complications during the procedure and falsely assume to have survived the most dangerous part when reaching post-anesthetic care units. 1 However, postoperative...
2020 22 Oct
Syncope is a heterogeneous syndrome with complex underlying mechanisms. The spectrum of patients presenting with syncope is broad, which requires appropriate, often individualized diagnosis paths. “Patients presenting with syncope,...
2020 19 May
The rapid global distribution of COVID-19 is challenging healthcare systems worldwide. In many countries hospitals and ICU departments are overloaded or fear a potential collapse - the optimal allocation of healthcare resources is required. Healthcare...
2020 11 May
The rapid global distribution of the Coronavirus and the fear of collapsing healthcare systems have forced hospitals to concentrate on the treatment of COVID-19 patients and allocate their resources accordingly. As a consequence up to 80% of the elective...
2020 09 Mar
Heart Failure (HF) is a major and public health problem as it affects at least 26 million people worldwide and will dramatically increase with an ageing population. Currently 5.7 million people suffer from HF in the US with an expected 46% increase...
2019 26 Aug
How can we get the most common, costly, and modifiable cardiovascular risk factor under control? Cardiovascular disease (CVD) is the number one cause of death with an upward trend beyond 30% and a tripling in costs between 2010 and 2030,...
2019 22 Feb
Aspects & challenges - Approaches & tools Head-up-tilt testing (HUTT) and autonomic function testing are essential diagnostic procedures in syncope assessment. With the advent of unique innovative methods to noninvasively monitor beat-to-beat blood...
Women's Health Community Supported by Hologic
Comprehensive information on women’s health issues and management, management and personalisation.
Enterprise Imaging Community
Advanced and scalable radiology solutions that can help improve care coordination, increase speed and facilitate accurate clinical decisions.
Decision Support Community Supported by Siemens Healthineers
Leading the way in highlighting useful and efficient decision support tools for improved patient outcomes.
Sepsis Community Supported by Abionic
Addressing the latest developments in sepsis and providing clinically useful information for diagnosis and treatment of patients.
COVID-19 Vaccines Prevented 20 Million Deaths Worldwide
Findings from the first modelling study to quantify the impact of COVID-19... Read more
Omicron Has Half the Risk of Long COVID Compared to Delta
New research shows that the Omicron variant is less likely to cause Long-COVID... Read more
COVID-19 Lockdown and Weight Changes
It has been speculated that the COVID-19 stay-at-home orders and shutdown... Read more
JOIN OUR MANAGEMENT COMMUNITY